IND-Enabling Development of Rx100 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome.

Information

• Research Project
• 9790011

• ApplicationId

  9790011

• Core Project Number

• Full Project Number

  272201800052C-0-0-1

• Serial Number

• FOA Number

• Sub Project Id

• Project Start Date

  9/1/2018 - 7 years ago

• Project End Date

  8/31/2019 - 6 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2018

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• RXBIO, INC.

This contract supports the development of safe and effective MCMs to mitigate and/or treat tissue injuries arising from exposure to ionizing radiation from a radiological or nuclear incident, thereby leading to a reduction in radiation-associated morbidities and mortalities.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  1519121

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

• Ed Inst. Type

• Funding ICs

  OD:1519121\

• Funding Mechanism

  Non SBIR/STTR Contracts

• Study Section

• Study Section Name

• Organization Name

  RXBIO, INC.

• Organization Department

• Organization DUNS

  185698334

• Organization City

  JOHNSON CITY

• Organization State

  TN

• Organization Country

  UNITED STATES

• Organization Zip Code

  376043619

• Organization District

  UNITED STATES